BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
Florham Park, New Jersey - On March 30, 2026, BeyondSpring Inc. (NASDAQ: BYSI) shared its plan to present a poster at the 2026 Annual Meeting of the American Association for Cancer Research in San Diego, California from April 17 to 22, 2026. BeyondSpring, a clinical-stage entity focused on creating innovative treatments for cancer and other ailments, will participate in this event to showcase its research and advancements in the field. This initiative highlights the company's dedication to developing new therapies and addressing significant medical needs.
